Beta Bionics, Inc. · NASDAQ:BBNX

Hopman Mark sold 821 Beta Bionics, Inc. shares (Form 4)

Traded Oct 26, 2026 · Filed Oct 28, 2026

On Oct 26, 2026, Hopman Mark (Chief Commercial Officer) sold 821 Beta Bionics, Inc. shares at US$20.00 for US$16,420 under a trading plan, leaving 54,513 shares. Filed Oct 28, 2026 (Form 4).

Sold
821 shares
Price
US$20.00
Value
US$16,420
Holding after
54,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 26, 2026Common StockSale821US$20.0054,513Direct

Source

Download original · View original at SEC

Related